Literature DB >> 30637824

Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.

Milan Holeček1, Melita Vodeničarovová1.   

Abstract

The aim of the study was to examine whether a rat model of liver cirrhosis induced by carbon tetrachloride (CCl4) is a suitable model of muscle wasting and alterations in amino acid metabolism in cirrhotic humans. Rats were treated by intragastric gavage of CCl4 or vehicle for 45 days. Blood plasma and different muscle types-tibialis anterior (mostly white fibres), soleus (red muscle) and extensor digitorum longus (white muscle) - were analysed at the end of the study. Characteristic biomarkers of impaired hepatic function were found in the plasma of cirrhotic animals. The weights and protein contents of all muscles of CCl4-treated animals were lower when compared with controls. Increased concentrations of glutamine (GLN) and aromatic amino acids (phenylalanine and tyrosine) and decreased concentrations of branched-chain amino acids (BCAA), glutamate (GLU), alanine and aspartate were found in plasma and muscles. In the soleus muscle, GLN increased more and GLU and BCAA decreased less than in the extensor digitorum and tibialis muscles. Increased chymotrypsin-like activity (indicating enhanced proteolysis) and decreased α-ketoglutarate and ATP levels were found in muscles of cirrhotic animals. ATP concentration also decreased in blood plasma. It is concluded that a rat model of CCl4-induced cirrhosis is a valid model for the investigation of hepatic cachexia that exhibits alterations in line with a theory of role of ammonia in pathogenesis of BCAA depletion, citric cycle and mitochondria dysfunction, and muscle wasting in cirrhotic subjects. The findings indicate more effective ammonia detoxification to GLN in red than in white muscles.
© 2019 The Authors. International Journal of Experimental Pathology © 2019 International Journal of Experimental Pathology.

Entities:  

Keywords:  ammonia detoxification; cachexia; glutamine; liver cirrhosis

Mesh:

Substances:

Year:  2019        PMID: 30637824      PMCID: PMC6384501          DOI: 10.1111/iep.12299

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  41 in total

1.  Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle.

Authors:  Milan Holecek; Roman Kandar; Ludek Sispera; Miroslav Kovarik
Journal:  Amino Acids       Date:  2010-07-08       Impact factor: 3.520

2.  Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Silvia Nardelli; Barbara Lattanzi; Sabrina Torrisi; Francesca Greco; Alessio Farcomeni; Stefania Gioia; Manuela Merli; Oliviero Riggio
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-02       Impact factor: 11.382

3.  Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2019-01-13       Impact factor: 1.925

4.  Increased muscle protein catabolism caused by carbon tetrachloride hepatic injury in rats.

Authors:  F L Weber; P T Macechko; S R Kelson; E Karajiannis; M O Hassan
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

Review 5.  Branched-chain amino acids in liver disease: new aspects of long known phenomena.

Authors:  Mathias Plauth; Tatjana Schütz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-01       Impact factor: 4.294

6.  Evidence for valine intolerance in patients with cirrhosis.

Authors:  P Schauder; K Schröder; L Herbertz; K Langer; U Langenbeck
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

7.  Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease.

Authors:  F Blondé-Cynober; F Plassart; C Rey; C Coudray-Lucas; N Moukarbel; R Poupon; J Giboudeau; L Cynober
Journal:  Ann Nutr Metab       Date:  1994       Impact factor: 3.374

8.  Muscle metabolism and whole blood amino acid profile in patients with liver disease.

Authors:  Gitte Dam; Michael Sørensen; Mads Buhl; Thomas D Sandahl; Niels Møller; Peter Ott; Hendrik Vilstrup
Journal:  Scand J Clin Lab Invest       Date:  2015-08-04       Impact factor: 1.713

Review 9.  Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation.

Authors:  Milan Holeček
Journal:  Nutrition       Date:  2017-04-19       Impact factor: 4.008

10.  Protein tolerance to standard and high protein meals in patients with liver cirrhosis.

Authors:  Octavio Campollo; Dirk Sprengers; Gitte Dam; Hendrik Vilstrup; Neil McIntyre
Journal:  World J Hepatol       Date:  2017-05-18
View more
  9 in total

1.  Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2019-01-13       Impact factor: 1.925

2.  Effects of beta-hydroxy-beta-methylbutyrate supplementation on skeletal muscle in healthy and cirrhotic rats.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2019-07-18       Impact factor: 1.925

3.  Effects of low and high doses of fenofibrate on protein, amino acid, and energy metabolism in rat.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2020-09-01       Impact factor: 1.925

Review 4.  Influence of Histidine Administration on Ammonia and Amino Acid Metabolism: A Review.

Authors:  M Holeček
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

Review 5.  The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases.

Authors:  M Holeček
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

Review 6.  Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology.

Authors:  Ming-Ling Chang; Sien-Sing Yang
Journal:  Cells       Date:  2019-11-12       Impact factor: 6.600

7.  Synthesis and Anti-Hepatocarcinoma Effect of Amino Acid Derivatives of Pyxinol and Ocotillol.

Authors:  Ying Zhang; Hui Yu; Shuzheng Fu; Luying Tan; Junli Liu; Baisong Zhou; Le Li; Yunhe Liu; Caixia Wang; Pingya Li; Jinping Liu
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

8.  Uridine alleviates carbon tetrachloride-induced liver fibrosis by regulating the activity of liver-related cells.

Authors:  Wei V Zheng; Yaqin Li; Xianyi Cheng; Yanwei Xu; Tao Zhou; Dezhi Li; Yu Xiong; Shaobin Wang; Zaizhong Chen
Journal:  J Cell Mol Med       Date:  2021-12-30       Impact factor: 5.310

9.  Dual Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) on Amino Acid, Energy, and Protein Metabolism in the Liver and Muscles of Rats with Streptozotocin-Induced Type 1 Diabetes.

Authors:  Milan Holeček; Melita Vodeničarovová; Radana Fingrová
Journal:  Biomolecules       Date:  2020-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.